Stopped: Insufficient Enrollment for Meaningful Analysis/Incomplete or Inconclusive Data Collection. Reaching desired participation numbers of subjects and site was determined to be unfeasible within the two year time period the study was intended to last.
National multi-center non interventional study aiming at investigating the effectiveness and safety of the combination mifepristone-misoprostol prescribed in Canada to women for medical termination of pregnancy at or before 63 days gestational age through a multi-center prospective non interventional study design.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Effectiveness of mifepristone-misoprostol for medical abortion at or prior to 63 days of gestational age
Timeframe: 14 to 28 days
Safety of mifepristone-misoprostol for medical abortion at or prior to 63 days gestational age
Timeframe: 14 to 28 days